Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
Both gastric and colorectal cancers (CRC) are the most frequently occurring malignancies worldwide with the overall survival of these patients remains unsatisfied. Identification of tumor suppressor genes (TSG) silenced by promoter CpG methylation uncovers mechanisms of tumorigenesis and identifies...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3496708?pdf=render |
id |
doaj-b0cdfbb846294290b7a405a1eba97b12 |
---|---|
record_format |
Article |
spelling |
doaj-b0cdfbb846294290b7a405a1eba97b122020-11-24T21:45:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e4968310.1371/journal.pone.0049683Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.Hong ZhaoQinshan LiJian WangXianwei SuKa Man NgTian QiuLing ShanYun LingLinfang WangJianqiang CaiJianming YingBoth gastric and colorectal cancers (CRC) are the most frequently occurring malignancies worldwide with the overall survival of these patients remains unsatisfied. Identification of tumor suppressor genes (TSG) silenced by promoter CpG methylation uncovers mechanisms of tumorigenesis and identifies new epigenetic biomarkers for early cancer detection and prognosis assessment. Cystathionine-beta-synthase (CBS) functions in the folate metabolism pathway, which is intricately linked to methylation of genomic DNA. Dysregulation of DNA methylation contributes substantially to cancer development.To identify potential TSGs silenced by aberrant promoter methylation in CRC, we analyzed tumor and adjacent tissues from CRC cases using the Illumina Human Methylation45 BeadChip. We identified hypermethylation of the CBS gene in CRC samples, compared to adjacent tissues. Methylation and decreased mRNA expression of CBS were detected in most CRC cell lines by methylation-specific PCR and semiquantitative RT-PCR, as well as in gastric cancer. Treatment with 5-aza-2'-deoxycytidine and/or trichostatin A reversed methylation and restored CBS mRNA expression indicating a direct effect. Aberrant methylation was further detected in 31% of primary CRCs (29 of 96) and 55% of gastric tumors (11 of 20). In contrast, methylation was seldom found in normal tissues adjacent to the tumor. CBS methylation was associated with KRAS mutations in primary CRCs (P = 0.04, by χ(2)-test). However, no association was found between CBS methylation or KRAS mutations with cancer relapse/metastasis in Stage II CRC patients.A novel finding from this study is that the folate metabolism enzyme CBS mRNA levels are frequently downregulated through CpG methylation of the CBS gene in gastric cancer and CRC, suggesting that CBS functions as a tumor suppressor gene. These findings warrant further study of CBS as an epigenetic biomarker for molecular diagnosis of gastrointestinal cancers.http://europepmc.org/articles/PMC3496708?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hong Zhao Qinshan Li Jian Wang Xianwei Su Ka Man Ng Tian Qiu Ling Shan Yun Ling Linfang Wang Jianqiang Cai Jianming Ying |
spellingShingle |
Hong Zhao Qinshan Li Jian Wang Xianwei Su Ka Man Ng Tian Qiu Ling Shan Yun Ling Linfang Wang Jianqiang Cai Jianming Ying Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. PLoS ONE |
author_facet |
Hong Zhao Qinshan Li Jian Wang Xianwei Su Ka Man Ng Tian Qiu Ling Shan Yun Ling Linfang Wang Jianqiang Cai Jianming Ying |
author_sort |
Hong Zhao |
title |
Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. |
title_short |
Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. |
title_full |
Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. |
title_fullStr |
Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. |
title_full_unstemmed |
Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. |
title_sort |
frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
Both gastric and colorectal cancers (CRC) are the most frequently occurring malignancies worldwide with the overall survival of these patients remains unsatisfied. Identification of tumor suppressor genes (TSG) silenced by promoter CpG methylation uncovers mechanisms of tumorigenesis and identifies new epigenetic biomarkers for early cancer detection and prognosis assessment. Cystathionine-beta-synthase (CBS) functions in the folate metabolism pathway, which is intricately linked to methylation of genomic DNA. Dysregulation of DNA methylation contributes substantially to cancer development.To identify potential TSGs silenced by aberrant promoter methylation in CRC, we analyzed tumor and adjacent tissues from CRC cases using the Illumina Human Methylation45 BeadChip. We identified hypermethylation of the CBS gene in CRC samples, compared to adjacent tissues. Methylation and decreased mRNA expression of CBS were detected in most CRC cell lines by methylation-specific PCR and semiquantitative RT-PCR, as well as in gastric cancer. Treatment with 5-aza-2'-deoxycytidine and/or trichostatin A reversed methylation and restored CBS mRNA expression indicating a direct effect. Aberrant methylation was further detected in 31% of primary CRCs (29 of 96) and 55% of gastric tumors (11 of 20). In contrast, methylation was seldom found in normal tissues adjacent to the tumor. CBS methylation was associated with KRAS mutations in primary CRCs (P = 0.04, by χ(2)-test). However, no association was found between CBS methylation or KRAS mutations with cancer relapse/metastasis in Stage II CRC patients.A novel finding from this study is that the folate metabolism enzyme CBS mRNA levels are frequently downregulated through CpG methylation of the CBS gene in gastric cancer and CRC, suggesting that CBS functions as a tumor suppressor gene. These findings warrant further study of CBS as an epigenetic biomarker for molecular diagnosis of gastrointestinal cancers. |
url |
http://europepmc.org/articles/PMC3496708?pdf=render |
work_keys_str_mv |
AT hongzhao frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT qinshanli frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT jianwang frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT xianweisu frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT kamanng frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT tianqiu frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT lingshan frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT yunling frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT linfangwang frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT jianqiangcai frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer AT jianmingying frequentepigeneticsilencingofthefolatemetabolisinggenecystathioninebetasynthaseingastrointestinalcancer |
_version_ |
1725905312462929920 |